Myotonic disorders

Handbook of Clinical Neurology

Volumn 86, Issue , 2007, Pages 61-76

  Lehmann Horn, Frank ^a   Jurkat Rott, Karin ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649316987     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)86003-9     Document Type: Review

References (123)

1. Allen G.C. Paramyotonia and MH. Can J Anaesth 40 (1993) 580-581
2. Ashwood E.M., Russell W.J., and Burrow D.D. Hyperkalaemic periodic paralysis and anaesthesia. Anaesthesia 47 (1992) 579-584
3. Beck C.L., Fahlke C., and George Jr. A.L. Molecular basis for decreased muscle chloride conductance in the myotonic goat. Proc Natl Acad Sci USA 93 (1996) 11248-11252
4. Becker P.E. Myotonia Congenita and Syndromes Associated with Myotonia (1977), Thieme Press Inc, Stuttgart
5. Bendahhou S., Cummins T.R., Kwiecinski H., et al. Characterization of a new sodium channel mutation at arginine 1448 associated with moderate paramyotonia congenita in humans. J Physiol 518 (1999) 337-344
6. Benstead T.J., Camfield P.R., and King D.B. Treatment of paramyotonia congenita with acetazolamide. Can J Neurol Sci 14 (1987) 156-158
7. Berg J., Jiang H., Thornton C.A., et al. Truncated ClC-1 mRNA in myotonic dystrophy exerts a dominant-negative effect on the Cl current. Neurology 63 (2004) 2371-2375
8. Bouhours M., Sternberg D., Davoine C.S., et al. Functional characterization and cold sensitivity of T1313A, a new mutation of the skeletal muscle sodium channel causing paramyotonia congenita in humans. J Physiol 554 (2004) 635-647
9. Bouhours M., Luce S., Sternberg D., et al. A1152D mutation of the Na+ channel causes paramyotonia congenita and emphasizes the role of DIII/S4-S5 linker in fast inactivation. J Physiol 565 (2005) 415-427
10. Brancati F., Valente E.M., Davies N.P., et al. Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A. J Neurol Neurosurg Psychiatry 74 (2003) 1339-1341
11. Bretag A.H., Dawe S.R., Kerr D.I., et al. Myotonia as a side effect of diuretic action. Br J Pharmacol 71 (1980) 467-471
12. Brugnoni R., Galantini S., Confalonieri P., et al. Identification of three novel mutations in the major human skeletal muscle chloride channel gene (CLCN1), causing myotonia congenita. Hum Mutat 14 (1999) 447
13. Bryant S.H. Cable properties of external intercostal muscle fibres from myotonic and nonmyotonic goats. J Physiol 204 (1969) 539-550
14. Cannon S.C., Hayward L.J., Beech J., et al. Sodium channel inactivation is impaired in equine hyperkalemic periodic paralysis. J Neurophysiol 73 (1995) 1892-1899
15. Carr E.A., Spier S.J., Kortz G.D., et al. Laryngeal and pharyngeal dysfunction in horses homozygous for hyperkalemic periodic paralysis. J Am Vet Med Assoc 209 (1996) 798-803
16. Chahine M., George Jr. A.L., Zhou M., et al. Sodium channel mutations in paramyotonia congenita uncouple inactivation from activation. Neuron 12 (1994) 281-294
17. Charlet N., Savkur R.S., Singh G., et al. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 10 (2002) 45-53
18. Clark S.L., Luton F.H., and Cutler J.T. A form of congenital myotonia in goats. J Nerv Ment Dis 90 (1939) 297-309
19. Conne B., Stutz A., and Vassalli J.D. The 3′ untranslated region of messenger RNA: a molecular 'hotspot' for pathology?. Nat Med 6 (2000) 637-641
20. Cox J.H. An episodic weakness in four horses associated with intermittent serum hyperkalemia and the similarity of the disease to hyperkalemic periodic paralysis in man. Proc Am Assoc Equine Pract 31 (1985) 383-390
21. Deymeer F., Cakirkaya S., Serdaroglu P., et al. Transient weakness and compound muscle action potential decrement in myotonia congenita. Muscle Nerve 21 (1998) 1334-1337
22. Deymeer F., Lehmann-Horn F., Serdaroglu P., et al. Electrical myotonia in heterozygous carriers of recessive myotonia congenita. Muscle Nerve 22 (1999) 123-125
23. Drost G., Blok J.H., Stegeman D.F., et al. Propagation disturbance of motor unit action potentials during transient paresis in generalized myotonia: a high-density surface EMG study. Brain 124 (2001) 352-360
24. Dutzler R., Campbell E.B., Cadene M., et al. X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity. Nature 415 (2002) 287-294
25. Esteban J., Neumeyer A.M., McKenna-Yasek D., et al. Identification of two mutations and a polymorphism in the chloride channel CLCN-1 in patients with Becker's generalized myotonia. Neurogenetics 1 (1998) 185-188
26. Fahlke C. Ion permeation and selectivity in ClC-type chloride channels. Am J Physiol Renal Physiol 280 (2001) F748-F757
27. Fournier E., Arzel M., Sternberg D., et al. Electromyography guides toward subgroups of mutations in muscle channelopathies. Ann Neurol 56 (2004) 650-661
28. George Jr. A.L., Crackower M.A., Abdalla J.A., et al. Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita). Nat Genet 3 (1993) 305-310
29. George Jr. A.L., Sloan-Brown K., Fenichel G.M., Mitchell, et al. Nonsense and missense mutations of the muscle chloride channel gene in patients with myotonia congenita. Hum Mol Genet 3 (1994) 2071-2072
30. Griggs R.C., Moxley R., Riggs J.E., et al. Effects of acetazolamide on myotonia. Ann Neurol 3 (1978) 531-537
31. Haass A., Ricker K., Rudel R., et al. Clinical study of paramyotonia congenita with and without myotonia in a warm environment. Muscle Nerve 4 (1981) 388-395
32. + channel mutation alters molecular transitions between the open and inactivated states. J Physiol 497 (1996) 349-364
33. Heiman-Patterson T., Martino C., Rosenberg H., et al. Malignant hyperthermia in myotonia congenita. Neurology 38 (1988) 810-812
34. Heine R., Pika U., and Lehmann-Horn F. A novel SCN4A mutation causing myotonia aggravated by cold and potassium. Hum Mol Genet 2 (1993) 1349-1353
35. Heine R., George Jr. A.L., Pika U., et al. Proof of a non-functional muscle chloride channel in recessive myotonia congenita (Becker) by detection of a 4 base pair deletion. Hum Mol Genet 3 (1994) 1123-1128
36. Iaizzo P., and Lehmann-Horn F. Anesthetic complications in muscle disorders. Anesthesiology 82 (1995) 1093-1096
37. Jurkat-Rott K., McCarthy T., and Lehmann-Horn F. Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve 23 (2000) 4-17
38. Jurkat-Rott K., Mitrovic N., Hang C., et al. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci USA 97 (2000) 9549-9554
39. Jurkat-Rott K., Muller-Höcker J., Pongratz D., et al. Diseases associated with ion channel and ion transporter defects: chloride and sodium channel myotonias. In: Karpati G. (Ed). Structural and Molecular Basis of Skeletal Muscle Diseases (2002), ISN Neuropath Press, Basel 90-94
40. Jurkat-Rott K., and Lehmann-Horn F. Muscle channelopathies and critical points in functional and genetic studies. J Clin Invest 115 (2005) 2000-2009
41. Jurkat-Rott K., and Lehmann-Horn F. Hyperkalemic periodic paralysis type I. Gene Reviews at GeneTests: Medical Genetics Information Resource [database online] (2005), University of Washington, Seattle. http://www.genetests.org Funded by NIH. Copyright, Available at
42. Kelly P., Yang W.S., Costigan D., et al. Paramyotonia congenita and hyperkalemic periodic paralysis associated with a Met 1592 Val substitution in the skeletal muscle sodium channel alpha subunit - a large kindred with a novel phenotype. Neuromuscul Disord 7 (1997) 105-111
43. Kim J., Hahn Y., Sohn E.H., et al. Phenotypic variation of a Thr704Met mutation in skeletal sodium channel gene in a family with paralysis periodica paramyotonica. J Neurol Neurosurg Psychiatry 70 (2001) 618-623
44. Koch M.C., Steinmeyer K., Lorenz C., et al. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 257 (1992) 797-800
45. Koch M.C., Baumbach K., George A.L., et al. Paramyotonia congenita without paralysis on exposure to cold: a novel mutation in the SCN4A gene (Val1293Ile). Neuroreport 6 (1995) 2001-2004
46. Koty P.P., Pegoraro E., Hobson G., et al. Myotonia and the muscle chloride channel: dominant mutations show variable penetrance and founder effect. Neurology 47 (1996) 963-968
47. Kubisch C., Schmidt-Rose T., Fontaine B., et al. ClC-1 chloride channel mutations in myotonia congenita: variable penetrance of mutations shifting the voltage dependence. Hum Mol Genet 7 (1998) 1753-1760
48. Lacomis D., Gonzales J.T., and Giuliani M.J. Fluctuating clinical myotonia and weakness from Thomsen's disease occurring only during pregnancies. Clin Neurol Neurosurg 101 (1999) 133-136
49. Lehmann-Horn F., and Jurkat-Rott K. Voltage-gated ion channels and hereditary disease. Physiol Rev 79 (1999) 1317-1372
50. Lehmann-Horn F., Rudel R., and Ricker K. Membrane defects in paramyotonia congenita (Eulenburg). Muscle Nerve 10 (1987) 633-641
51. Lehmann-Horn F., and Iaizzo P.A. Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?. Br J Anaesth 65 (1990) 692-697
52. + channel defect causes myotonia. Muscle Nerve 13 (1990) 528-535
53. Lehmann-Horn F., Rudel R., and Ricker K. Non-dystrophic myotonias and periodic paralyses. Neuromuscul Disord 3 (1993) 161-168
54. Lehmann-Horn F., Mailänder V., Heine R., et al. Myotonia levior is a chloride channel disorder. Hum Mol Genet 4 (1995) 1397-1402
55. Lehmann-Horn F., Rudel R., and Jurkat-Rott K. Non-dystrophic myotonias and periodic paralyses. In: Engel A.G., and Franzini-Armstrong C. (Eds). Myology. 3rd edn. (2004), McGraw-Hill, New York 1257-1300
56. Lerche H., Heine R., Pika U., et al. Human sodium channel myotonia: slowed channel inactivation due to substitutions for a glycine within the III-IV linker. J Physiol 470 (1993) 13-22
57. + channel mutation in adult human skeletal muscle. Ann Neurol 39 (1996) 599-608
58. + channel probed by cysteine mutagenesis. J Physiol (Lond) 505 (1997) 345-352
59. Lipicky R.J., Bryant S.H., and Salmon J.H. Cable parameters, sodium, potassium, chloride, and water content, and potassium efflux in isolated external intercostal muscle of normal volunteers and patients with myotonia congenita. J Clin Invest 50 (1971) 2091-2103
60. Liquori C.L., Ricker K., Moseley M.L., et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293 (2001) 864-867
61. Lorenz C., Meyer-Kleine C., Steinmeyer K., et al. Genomic organization of the human muscle chloride channel ClC-1 and analysis of novel mutations leading to Becker-type myotonia. Hum Mol Genet 3 (1994) 941-946
62. Mailänder V., Heine R., Deymeer F., et al. Novel muscle chloride channel mutations and their effects on heterozygous carriers. Am J Hum Genet 58 (1996) 317-324
63. Mankodi A., Takahashi M.P., Jiang H., et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 10 (2002) 35-44
64. Mastaglia F.L. Adverse effects of drugs on muscle. Drugs 24 (1982) 304-321
65. McClatchey A.I., Van den Bergh P., Pericak-Vance M.A., et al. Temperature-sensitive mutations in the III-IV cytoplasmic loop region of the skeletal muscle sodium channel gene in paramyotonia congenita. Cell 68 (1992) 769-774
66. Meyer-Kleine C., Steinmeyer K., Ricker K., et al. Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN1) leading to myotonia. Am J Hum Genet 57 (1995) 1325-1334
67. Mindell J.A., Maduke M., Miller C., et al. Projection structure of a ClC-type chloride channel at 6.5 A resolution. Nature 409 (2001) 219-223
68. + channel by the V1589M mutation. J Physiol 478 (1994) 395-402
69. Mitrovic N., George Jr. A.L., Lerche H., et al. Different effects on gating of three myotonia-causing mutations in the inactivation gate of the human muscle sodium channel. J Physiol 487 (1995) 107-114
70. Mohammadi B., Mitrovic N., Lehmann-Horn F., et al. Mechanisms of cold sensitivity of paramyotonia congenita mutation R1448H and overlap syndrome mutation M1360V. J Physiol 547 (2003) 691-698
71. Mohammadi B., Jurkat-Rott K., Alekov A.K., et al. Preferred mexiletine block of human sodium channels with IVS4 mutations and its pH-dependence. Pharmacogenet Genomics 15 (2005) 235-244
72. Nagamitsu S., Matsuura T., Khajavi M., et al. A "dystrophic" variant of autosomal recessive myotonia congenita caused by novel mutations in the CLCN1 gene. Neurology 55 (2000) 1697-1703
73. Newberg L.A., Lambert E.H., and Gronert G.A. Failure to induce malignant hyperthermia in myotonic goats. Br J Anaesth 55 (1983) 57-60
74. Newman B., Meola G., O'Donovan D.G., et al. Proximal myotonic myopathy (PROMM) presenting as myotonia during pregnancy. Neuromuscul Disord 9 (1999) 144-149
75. Okuda S., Kanda F., Nishimoto K., et al. Hyperkalemic periodic paralysis and paramyotonia congenita - a novel sodium channel mutation. J Neurol 248 (2001) 1003-1004
76. Orrell R.W., Jurkat-Rott K., Lehmann-Horn F., et al. Familial cramp due to potassium-aggravated myotonia. J Neurol Neurosurg Psychiatry 65 (1998) 569-572
77. Paasuke R.T., and Brownell A.K. Serum creatine kinase level as a screening test for susceptibility to malignant hyperthermia. JAMA 255 (1986) 769-771
78. Palade P.T., and Barchi R.L. On the inhibition of muscle membrane chloride conductance by aromatic carboxylic acids. J Gen Physiol 69 (1977) 879-896
79. Papponen H., Toppinen T., Baumann P., et al. Founder mutations and the high prevalence of myotonia congenita in northern Finland. Neurology 53 (1999) 297-302
80. Plassart E., Eymard B., Maurs L., et al. Paramyotonia congenita: genotype to phenotype correlations in two families and report of a new mutation in the sodium channel gene. J Neurol Sci 142 (1996) 126-133
81. Plassart-Schiess E., Gervais A., Eymard B., et al. Novel muscle chloride channel (CLCN1) mutations in myotonia congenita with various modes of inheritance including incomplete dominance and penetrance. Neurology 50 (1998) 1176-1179
82. Ptacek L.J., George Jr. A.L., Barchi R.L., et al. Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita. Neuron 8 (1992) 891-897
83. Ptacek L.J., Tawil R., Griggs R.C., et al. Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis. Neurology 44 (1994) 1500-1503
84. Pusch M. Myotonia caused by mutations in the muscle chloride channel gene CLCN1. Hum Mutat 19 (2002) 423-434
85. Pusch M., Steinmeyer K., Koch M.C., et al. Mutations in dominant human myotonia congenita drastically alter the voltage dependence of the ClC-1 chloride channel. Neuron 15 (1995) 1455-1463
86. Ranum L.P., Rasmussen P.F., Benzow K.A., et al. Genetic mapping of a second myotonic dystrophy locus. Nat Genet 19 (1998) 196-198
87. Ricker K., Haass A., and Glötzner F. Fenoterol precipitating myotonia in a minimally affected case of recessive myotonia congenita. J Neurol 219 (1978) 279-282
88. Ricker K., Haass A., Hertel G., et al. Transient muscular weakness in severe recessive myotonia congenita. Improvement of isometric muscle force by drugs relieving myotonic stiffness. J Neurol 218 (1978) 253-262
89. Ricker K., Böhlen R., and Rohkamm R. Different effectiveness of tocainide and hydrochlorothiazide in paramyotonia congenita with hyperkalemic episodic paralysis. Neurology 33 (1983) 1615-1618
90. Ricker K., Rudel R., Lehmann-Horn F., et al. Muscle stiffness and electrical activity in paramyotonia congenita. Muscle Nerve 9 (1986) 299-305
91. Ricker K., Lehmann-Horn F., and Moxley R. Myotonia fluctuans. Arch Neurol 47 (1990) 268-272
92. Ricker K., Koch M.C., Lehmann-Horn F., et al. Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 44 (1994) 1448-1452
93. Ricker K., Moxley R., Heine R., et al. Myotonia fluctuans. A third type of muscle sodium channel disease. Arch Neurol 51 (1994) 1095-1102
94. Ricker K., Grimm T., Koch M.C., et al. Linkage of proximal myotonic myopathy to chromosome 3q. Neurology 52 (1999) 170-171
95. Risseeuw J.J., Oudshoorn J.H., van der Straaten P.J., et al. Myotonic dystrophy in pregnancy: a report of two cases within one family. Eur J Obstet Gynecol Reprod Biol 73 (1997) 145-148
96. Rosenfeld J., Sloan-Brown K., and George Jr. A.L. A novel muscle sodium channel mutation causes painful congenital myotonia. Ann Neurol 42 (1997) 811-814
97. Rudel R., and Lehmann-Horn F. Paramyotonia, potassium-aggravated myotonias and periodic paralyses. 37th ENMC International Workshop, Naarden, The Netherlands, 8-10 December 1995. Neuromuscul Disord 7 (1997) 127-132
98. Rudel R., Ricker K., and Lehmann-Horn F. Transient weakness and altered membrane characteristic in recessive generalized myotonia (Becker). Muscle Nerve 11 (1988) 202-211
99. Rudolph J.A., Spier S.J., Byrns G., et al. Periodic paralysis in quarter horses: a sodium channel mutation disseminated by selective breeding. Nat Genet 2 (1992) 144-147
100. Sangiuolo F., Botta A., Mesoraca A., et al. Identification of five new mutations and three novel polymorphisms in the muscle chloride channel gene (CLCN1) in 20 Italian patients with dominant and recessive myotonia congenita. Hum Mutat 11 (1998) 331
101. Sansone V., Griggs R.C., and Moxley R. Hypothyroidism unmasking proximal myotonic myopathy. Neuromuscul Disord 10 (2000) 165-172
102. Sasaki R., Ichiyasu H., Ito N., et al. Novel chloride channel gene mutations in two unrelated Japanese families with Becker's autosomal recessive generalized myotonia. Neuromuscul Disord 9 (1999) 587-592
103. Sasaki R., Ito N., Shimamura M., et al. A novel CLCN1 mutation: P480T in a Japanese family with Thomsen's myotonia congenita. Muscle Nerve 24 (2001) 357-363
104. Saviane C., Conti F., and Pusch M. The muscle chloride channel ClC-1 has a double-barreled appearance that is differentially affected in dominant and recessive myotonia. J Gen Physiol 113 (1999) 457-468
105. Sloan-Brown K., and George Jr. A.L. Inheritance of three distinct muscle chloride channel gene (CLCN1) mutations in a single recessive myotonia congenita family. Neurology 48 (1997) 552-553
106. Spaans F., Theunissen P., Reekers A.D., et al. Schwartz-Jampel syndrome: I. Clinical, electromyographic, and histologic studies. Muscle Nerve 13 (1990) 516-527
107. Steinmeyer K., Klocke R., Ortland C., et al. Inactivation of muscle chloride channel by transposon insertion in myotonic mice. Nature 354 (1991) 304-308
108. Sun C., Tranebjaerg L., Torbergsen T., et al. Spectrum of CLCN1 mutations in patients with myotonia congenita in Northern Scandinavia. Eur J Hum Genet 9 (2001) 903-909
109. Thomas A., Leopold U., and Winkler H. Maligne hyperthermie bei paramyotonia congenita. Anaesthesiol Reanim 13 (1988) 295-300
110. Trudell R.G., Kaiser K.K., and Griggs R.C. Acetazolamide-responsive myotonia congenita. Neurology 37 (1987) 488-491
111. Tsujino A., Maertens C., Ohno K., et al. Myasthenic syndrome caused by mutation of the SCN4A sodium channel. Proc Natl Acad Sci USA 100 (2003) 7377-7382
112. 1306-to-alanine mutation in the adult muscle sodium channel α-subunit gene. Anesthesiology 82 (1995) 1097-1103
113. Wagner S., Lerche H., Mitrovic N., et al. A novel sodium channel mutation causing a hyperkalemic paralytic and paramyotonic syndrome with variable clinical expressivity. Neurology 49 (1997) 1018-1025
114. Wagner S., Deymeer F., Kurz L.L., et al. The dominant chloride channel mutant G200R causing fluctuating myotonia: clinical findings, electrophysiology, and channel pathology. Muscle Nerve 21 (1998) 1122-1128
115. 23Na MRI in vivo. Neurology 67 (2006) 1151-1158
116. Weiss M.D., and Mayer R.F. Temperature-sensitive repetitive discharges in paramyotonia congenita. Muscle Nerve 20 (1997) 195-197
117. White G.R., and Plaskett J. "Nervous", "stiff-legged", or "fainting" goats. Am Vet Rev 28 (1904) 556-560
118. Wu F.F., Takahashi M.P., Pegoraro E., et al. A new mutation in a family with cold-aggravated myotonia disrupts Na(+) channel inactivation. Neurology 56 (2001) 878-884
119. Wu F.F., Ryan A., Devaney J., et al. Novel CLCN1 mutations with unique clinical and electro-physiological consequences. Brain 125 (2002) 2392-2407
120. Wu F.F., Gordon E., Hoffman E.P., et al. A C-terminal skeletal muscle sodium channel mutation associated with myotonia disrupts fast inactivation. J Physiol 565 (2005) 371-380
121. Zhang J., George Jr. A.L., Griggs R.C., et al. Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita. Neurology 47 (1996) 993-998
122. Zhang J., Bendahhou S., Sanguinetti M.C., et al. Functional consequences of chloride channel gene (CLCN1) mutations causing myotonia congenita. Neurology 54 (2000) 937-942
123. Zhou J., Spier S.J., Beech J., et al. Pathophysiology of sodium channelopathies: correlation of normal/mutant mRNA ratios with clinical phenotype in dominantly inherited periodic paralysis. Hum Mol Genet 3 (1994) 1599-1603